141 related articles for article (PubMed ID: 2565902)
1. Failure of selective antagonists (CH-38083 and idazoxan) to distinguish between prejunctional and postjunctional alpha 2-adrenoreceptors.
Lonart G; Harsing LG; Folly G; Vizi ES
J Auton Pharmacol; 1989 Apr; 9(2):149-58. PubMed ID: 2565902
[TBL] [Abstract][Full Text] [Related]
2. Effect of CH-38083, a selective antagonist of alpha 2-adrenoceptors, on renal sympathetic function.
Dóda M; Vizi ES
Neuropharmacology; 1989 Feb; 28(2):135-40. PubMed ID: 2566132
[TBL] [Abstract][Full Text] [Related]
3. Idazoxan and CH-38083 affect gastric secretion by inhibiting alpha-2 adrenoceptors at vagal and sympathetic pathways.
Del Tacca M; Blandizzi C; Bernardini MC; Vizi SE
Acta Physiol Hung; 1990; 75 Suppl():81-2. PubMed ID: 1973574
[No Abstract] [Full Text] [Related]
4. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
Doxey JC; Roach AG; Strachan DA; Virdee NK
Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
[TBL] [Abstract][Full Text] [Related]
5. CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors.
Vizi ES; Harsing LG; Gaal J; Kapocsi J; Bernath S; Somogyi GT
J Pharmacol Exp Ther; 1986 Aug; 238(2):701-6. PubMed ID: 2874217
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of the enantiomers of idazoxan: possible separation between their alpha-adrenoceptor blocking effects.
Dabire H; Dausse JP; Mouille P; Fournier B; Cardot A; Meyer P; Schmitt H
Clin Exp Hypertens A; 1986; 8(3):387-409. PubMed ID: 2873908
[TBL] [Abstract][Full Text] [Related]
7. The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
Elliott HL; Jones CR; Vincent J; Lawrie CB; Reid JL
Clin Pharmacol Ther; 1984 Aug; 36(2):190-6. PubMed ID: 6146423
[TBL] [Abstract][Full Text] [Related]
8. Cardiac alpha-adrenoceptors: postjunctional and prejunctional.
Rand MJ; Tung LH; Louis WJ; Story DF
J Mol Cell Cardiol; 1986 Nov; 18 Suppl 5():17-32. PubMed ID: 2433457
[TBL] [Abstract][Full Text] [Related]
9. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
Doxey JC; Roach AG; Smith CF
Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.
Sanger DJ
Psychopharmacology (Berl); 1989; 99(1):117-21. PubMed ID: 2571173
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of presynaptic alpha 1-adrenoceptors in the effects of idazoxan and prazosin on 3H-noradrenaline release from tail arteries of SHR.
Hicks PE; Najar M; Vidal M; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):354-61. PubMed ID: 2877400
[TBL] [Abstract][Full Text] [Related]
12. Alpha-adrenoreceptor reagents. 4. Resolution of some potent selective prejunctional alpha 2-adrenoreceptor antagonists.
Welbourn AP; Chapleo CB; Lane AC; Myers PL; Roach AG; Smith CF; Stillings MR; Tulloch IF
J Med Chem; 1986 Oct; 29(10):2000-3. PubMed ID: 2876101
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of postjunctional alpha-1 and alpha-2 adrenoreceptors increases proximal urethral perfusion pressure in the pithed rat.
Willette RN; Sauermelch C; Hieble JP
J Auton Pharmacol; 1989 Feb; 9(1):63-70. PubMed ID: 2566616
[TBL] [Abstract][Full Text] [Related]
14. The bradycardic and mydriatic effects of chlordimeform and its demethylated analogs in the rat: antagonism by idazoxan but not by prazosin.
Hsu WH; Smith BE; Hollingworth RM
Life Sci; 1988; 43(23):1897-904. PubMed ID: 2849009
[TBL] [Abstract][Full Text] [Related]
15. Effects of desipramine on stimulation-induced contractions of the vas deferens of rats pretreated either chronically with desipramine or acutely with idazoxan.
Doxey JC; Roach AG; Samuel J
Clin Sci (Lond); 1985; 68 Suppl 10():155s-159s. PubMed ID: 2857613
[TBL] [Abstract][Full Text] [Related]
16. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats.
Hirohashi M; Tanaka M; Suzuki I; Akashi A
Arch Int Pharmacodyn Ther; 1990; 306():75-86. PubMed ID: 1981668
[TBL] [Abstract][Full Text] [Related]
17. GYKI-12743 a new postsynaptic vascular alpha-adrenoceptor antagonist.
Rabloczky G; Jaszlits L; Horváth E
Acta Physiol Hung; 1991; 77(3-4):257-67. PubMed ID: 1684485
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the selectivity of alpha-adrenoreceptor blocking drugs for postsynaptic alpha 1- and alpha 2-adrenoreceptors in a simple animal model.
Timmermans PB; Van Meel JC; Van Zwieten PA
J Auton Pharmacol; 1980 Nov; 1(1):53-60. PubMed ID: 6122689
[TBL] [Abstract][Full Text] [Related]
19. [Action of idazoxan on tachycardia following electric stimulation of the thoracic sympathetic chain in the rat].
Dabiré H; Fournier B; Schmitt H
C R Seances Soc Biol Fil; 1986; 180(2):170-3. PubMed ID: 2877721
[TBL] [Abstract][Full Text] [Related]
20. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
Harsing LG; Vizi ES
J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
